These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28914666)

  • 21. MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells.
    Park J; Ryu DR; Li JJ; Jung DS; Kwak SJ; Lee SH; Yoo TH; Han SH; Lee JE; Kim DK; Moon SJ; Kim K; Han DS; Kang SW
    Am J Physiol Renal Physiol; 2008 Sep; 295(3):F749-57. PubMed ID: 18579703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MCP-1 promotes invasion and adhesion of human ovarian cancer cells.
    Furukawa S; Soeda S; Kiko Y; Suzuki O; Hashimoto Y; Watanabe T; Nishiyama H; Tasaki K; Hojo H; Abe M; Fujimori K
    Anticancer Res; 2013 Nov; 33(11):4785-90. PubMed ID: 24222114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological characterization of INCB3344, a small molecule antagonist of human CCR2.
    Shin N; Baribaud F; Wang K; Yang G; Wynn R; Covington MB; Feldman P; Gallagher KB; Leffet LM; Lo YY; Wang A; Xue CB; Newton RC; Scherle PA
    Biochem Biophys Res Commun; 2009 Sep; 387(2):251-5. PubMed ID: 19576173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MCP-1: chemoattractant with a role beyond immunity: a review.
    Yadav A; Saini V; Arora S
    Clin Chim Acta; 2010 Nov; 411(21-22):1570-9. PubMed ID: 20633546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of MCP-1-CCR2 ligand-receptor axis in chondrocyte degradation and disease progress in knee osteoarthritis.
    Xu YK; Ke Y; Wang B; Lin JH
    Biol Res; 2015 Nov; 48():64. PubMed ID: 26578310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-content analysis of CCR2 antagonists on human primary monocytes.
    Kredel S; Wolff M; Hobbie S; Bieler M; Gierschik P; Heilker R
    J Biomol Screen; 2011 Aug; 16(7):683-93. PubMed ID: 21540351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the CCL2-CCR2 signaling pathway: potential implications of statins beyond cardiovascular diseases.
    Gholamalizadeh H; Ensan B; Sukhorukov VN; Sahebkar A
    J Pharm Pharmacol; 2024 Jan; 76(2):138-153. PubMed ID: 38127312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance.
    Zhang XW; Qin X; Qin CY; Yin YL; Chen Y; Zhu HL
    Cancer Immunol Immunother; 2013 Mar; 62(3):563-70. PubMed ID: 23090289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of MCP-1/CCR2 signaling does not inhibit intimal proliferation in a mouse aortic transplant model.
    Alexis JD; Pyo RT; Chereshnev I; Katz J; Rollins BJ; Charo IF; Taubman MB
    J Vasc Res; 2008; 45(6):538-46. PubMed ID: 18463419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin as a natural regulator of monocyte chemoattractant protein-1.
    Karimian MS; Pirro M; Majeed M; Sahebkar A
    Cytokine Growth Factor Rev; 2017 Feb; 33():55-63. PubMed ID: 27743775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions.
    Nam BY; Paeng J; Kim SH; Lee SH; Kim DH; Kang HY; Li JJ; Kwak SJ; Park JT; Yoo TH; Han SH; Kim DK; Kang SW
    Apoptosis; 2012 Jan; 17(1):1-13. PubMed ID: 22006533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments.
    Kang YS; Cha JJ; Hyun YY; Cha DR
    Expert Opin Investig Drugs; 2011 Jun; 20(6):745-56. PubMed ID: 21466412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine sulfation of chemokine receptor CCR2 enhances interactions with both monomeric and dimeric forms of the chemokine monocyte chemoattractant protein-1 (MCP-1).
    Tan JHY; Ludeman JP; Wedderburn J; Canals M; Hall P; Butler SJ; Taleski D; Christopoulos A; Hickey MJ; Payne RJ; Stone MJ
    J Biol Chem; 2013 Apr; 288(14):10024-10034. PubMed ID: 23408426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
    Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
    J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
    Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
    DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2.
    Hemmerich S; Paavola C; Bloom A; Bhakta S; Freedman R; Grunberger D; Krstenansky J; Lee S; McCarley D; Mulkins M; Wong B; Pease J; Mizoue L; Mirzadegan T; Polsky I; Thompson K; Handel TM; Jarnagin K
    Biochemistry; 1999 Oct; 38(40):13013-25. PubMed ID: 10529171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury.
    Baeck C; Wehr A; Karlmark KR; Heymann F; Vucur M; Gassler N; Huss S; Klussmann S; Eulberg D; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Mar; 61(3):416-26. PubMed ID: 21813474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human pulmonary fibroblast-derived MCP-1 in cell activation and migration in experimental silicosis.
    Liu X; Fang S; Liu H; Wang X; Dai X; Yin Q; Yun T; Wang W; Zhang Y; Liao H; Zhang W; Yao H; Chao J
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):152-60. PubMed ID: 26163174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential expression of MCP-1 and its receptor CCR2 in glucose primed human mesangial cells.
    Janssen U; Sowa E; Marchand P; Floege J; Phillips AO; Radeke HH
    Nephron; 2002 Dec; 92(4):797-806. PubMed ID: 12399623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.